Extracorporeal circulation, optimized: A pilot study

Artificial Organs

Volumn 31, Issue 5, 2007, Pages 377-383

  Agati, Salvatore ^a   Ciccarello, Giuseppe ^b   Trimarchi, Eugenio Santo ^a   Grasso, Daniela ^b   Trimarchi, Giuseppe ^c   Stefano, Salvatore Di ^a   Carmelo, Mignosa ^a  

^a San Vincenzo Hospital   (Italy)

^b Enhanced Perfusion Service   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

Miniaturized cardiopulmonary bypass

Indexed keywords

BY PASS; BYPASS SYSTEMS; CARDIOPULMONARY BYPASS; CORONARY ARTERIES; END-POINTS; EXTRACORPOREAL CIRCULATION; GROUP III; MINIATURIZED CARDIOPULMONARY BYPASS; PHOSPHORYLCHOLINE; PILOT STUDIES;

BLOOD;

C REACTIVE PROTEIN; PHOSPHORYLCHOLINE;

ADULT; AGED; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL CIRCULATION; FEMALE; HEMATOCRIT; HUMAN; INTERMETHOD COMPARISON; MALE; PILOT STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

EID: 34247556084     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2007.00395.x     Document Type: Conference Paper

References (12)

1. Gibbon JH, Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. In:Recent Advances in Cardiovascular Physiology and Surgery. Minneapolis, MN:University of Minnesota, 1953:107 13.
2. Puskas JD, Williams WH, Duke PG, et al. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003 125:797 808.
3. Panico FC, Neptune WB. A mechanism to eliminate the donor blood prime from the pump oxygenators. Surg Forum 1959 10:605 9.
4. Cooley DA, Beaull AC, Grondin P. Open heart operations with disposable oxygenators, 5% dextrose and normothermia. Surgery 1962 52:713 9.
5. Mossad E, Estafanous F. Con: a hematocrit of 20% is not adequate for separation from cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1996 10:294 5.
6. Fang WC, Helm RE, Krieger KH, et al. Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 1997 96 (Suppl. 2 194 9.
7. DeFoe GR, Ross CS, Olmstead EM, et al. Lowest hematocrit on bypass and adverse outcome associated with coronary artery bypass grafting. Ann Thorac Surg 2001 71:769 76.
8. Ranucci M, Pazzaglia A, Isgro G, et al. Closed, phosphorylcholine-coated circuit and reduction of systemic heparinization for cardiopulmonary bypass: the intraoperative ECMO concept. Int J Artif Organs 2002 25:875 81.
9. Aldea GS, Soltow LO, Chandler WL, et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 2002 123:742 55.
10. De Somer F, Van Belleghem Y, Caes F, et al. Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass. Perfusion 2002 17:39 44.
11. Gaudino M, Zamparelli R, Andreotti F, et al. Normothermia does not improve postoperative hemostasis nor does it reduce inflammatory activation in patients undergoing primary isolated coronary artery bypass. J Thorac Cardiovasc Surg 2002 123:1092 100.
12. Rastan AJ, Bittner HB, Gummert JF, et al. On-pump beating heart versus off-pump coronary artery bypass surgery - evidence of pump-induced myocardial injury. Eur J Cardiothorac Surg 2005 27:1057 64.